Plaque Modification and Removal Devices Market Size & Forecasts 2026-2035, By Segments (Product, Application, End Use), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (Medtronic, Boston Scientific, Abbott, Philips, Cardiovascular Systems)

Market Outlook

Plaque Modification and Removal Devices Market size is anticipated to rise from USD 2.13 billion in 2025 to USD 4.77 billion by 2035, reflecting a CAGR surpassing 8.4% over the forecast horizon of 2026-2035. The estimated revenue for 2026 is USD 2.29 billion.

• Base Year Value (2025): USD 2.13 Billion
• CAGR (2026-2035): 8.4%
• Forecast Year Value (2035): USD 4.77 Billion
• Historical Data Period: 2021-2025
• Largest Region: North America
• Forecast Period: 2026-2035

Key Takeaways

• North America region captured over 49% revenue share in 2025, supported by advanced cardiovascular treatment.
• Asia Pacific region will witness more than 9.5% CAGR during the forecast period, attributed to rising heart disease prevalence.
• Capturing 58.8% plaque modification and removal devices market share in 2025, coronary artery disease segment expanded its dominance, supported by high disease prevalence.
• The hospitals segment reached 68.6% revenue share in 2025, fueled by advanced surgical facilities.
• With 41.2% market share in 2025, atherectomy devices segment’s growth was led by effective plaque removal.
• Key companies dominating the plaque modification and removal devices market are Medtronic (Ireland), Boston Scientific (USA), Abbott (USA), Philips (Netherlands), Cardiovascular Systems (USA), Terumo (Japan), B. Braun (Germany), Biotronik (Germany), Cordis (USA), Asahi Intecc (Japan).

Market Dynamics

Adoption of Plaque Modification and Removal Devices in Dental Care

The increasing awareness of oral health and the significance of preventive dental care are driving the adoption of plaque modification and removal devices in the dental care sector. As consumers become more health-conscious, they are seeking advanced solutions that ensure effective plaque management and promote overall dental hygiene. According to the American Dental Association, there has been a notable rise in preventive dental visits, which correlates with the growing demand for innovative plaque management tools. This trend presents strategic opportunities for established players to enhance their product portfolios while enabling new entrants to capitalize on emerging consumer preferences for effective oral care solutions.

Integration of Advanced Imaging and AI in Dental Devices

The integration of advanced imaging technology and artificial intelligence in dental devices is reshaping the plaque modification and removal devices market. Enhanced imaging capabilities allow for precise diagnosis and treatment planning, significantly improving patient outcomes. Companies such as Dentsply Sirona are utilizing AI to streamline workflows and enhance the accuracy of plaque detection, which not only boosts efficiency but also fosters patient trust. This technological evolution opens avenues for collaboration between tech firms and dental manufacturers, encouraging innovation and providing a competitive edge for those who can effectively leverage these advancements in their offerings.

Development of Minimally Invasive and Automated Dental Care Tools

The shift towards minimally invasive and automated dental care tools is transforming the landscape of the plaque modification and removal devices market. Patients increasingly prefer procedures that minimize discomfort and recovery time, prompting manufacturers to innovate in this direction. The World Health Organization highlights the importance of patient-centered care, which aligns with the trend of developing tools that enhance the patient experience. This focus on automation and minimally invasive techniques not only attracts a broader patient demographic but also allows established firms to differentiate their products while providing new entrants with a clear pathway to market entry through innovative solutions.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Adoption of plaque modification and removal devices in dental care	3.00%	Short term (≤ 2 yrs)	North America, Europe (spillover: Asia Pacific)	Medium	Fast
Integration of advanced imaging and AI in dental devices	2.70%	Medium term (2–5 yrs)	Asia Pacific, North America (spillover: Europe)	Low	Moderate
Development of minimally invasive and automated dental care tools	2.70%	Long term (5+ yrs)	Europe, Asia Pacific (spillover: North America)	Low	Slow

Industry Restraints:

Regulatory Compliance Burdens

The plaque modification and removal devices market faces significant constraints due to stringent regulatory compliance requirements that vary across regions. These regulations, established by bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), can create operational inefficiencies for manufacturers. For instance, the lengthy approval processes for new devices often lead to delays in market entry and increased costs, which can deter innovation. Companies like Philips have reported challenges in navigating these regulatory landscapes, resulting in extended timelines for product launches. As a consequence, both established firms and new entrants may find themselves hampered in their ability to respond swiftly to market demands, ultimately slowing the evolution of the sector.

Supply Chain Vulnerabilities

The ongoing disruptions in global supply chains have emerged as a critical restraint affecting the plaque modification and removal devices market. Factors such as geopolitical tensions, the COVID-19 pandemic, and raw material shortages have led to significant delays and increased costs for manufacturers. For example, Medtronic has highlighted challenges in sourcing key components, which not only impacts production timelines but also raises concerns about product availability for healthcare providers. These vulnerabilities create a competitive disadvantage for companies unable to secure reliable supply chains, forcing them to either increase prices or limit product offerings. In the near to medium term, as the industry grapples with these supply chain issues, market participants will need to prioritize resilience strategies, potentially reshaping their operational frameworks to navigate these persistent challenges.

Regional Forecast

North America Market Statistics:

North America represented over 49% of the global plaque modification and removal devices market in 2025, solidifying its position as the largest regional player. This dominance is driven by a combination of advanced healthcare infrastructure, increasing prevalence of cardiovascular diseases, and heightened consumer awareness regarding preventive health measures. The region’s regulatory environment, characterized by stringent guidelines from agencies like the Food and Drug Administration (FDA), has fostered innovation and safety in medical devices, thereby enhancing consumer trust. Additionally, the ongoing digital transformation within healthcare, including telemedicine and data analytics, has reshaped patient engagement and treatment efficiency, positioning North America as a leader in the market. As healthcare spending continues to rise, the region offers substantial opportunities for growth in the plaque modification and removal devices market, appealing to investors and strategists alike.

The United States anchors the North American market for plaque modification and removal devices, reflecting a robust demand driven by an aging population and increasing lifestyle-related health issues. The U.S. healthcare system's emphasis on advanced cardiovascular treatments is evidenced by initiatives from the American Heart Association, which promote innovative treatment solutions. Moreover, the competitive landscape is marked by significant investments from leading companies like Medtronic and Boston Scientific, which are actively developing cutting-edge technologies to meet the evolving needs of healthcare providers and patients. This strategic focus on innovation, coupled with a favorable reimbursement landscape, positions the U.S. as a critical player in the regional market. The implications of these dynamics extend beyond national borders, reinforcing North America's leadership in the plaque modification and removal devices market.

Canada also plays a pivotal role in the North American plaque modification and removal devices market, characterized by a strong public health system that prioritizes cardiovascular health. The Canadian government, through initiatives led by Health Canada, has been proactive in regulating medical devices to ensure safety and efficacy, fostering a favorable environment for market growth. Consumer preferences in Canada increasingly lean towards minimally invasive procedures, driving demand for innovative plaque modification technologies. Companies like Abbott Laboratories are responding by tailoring their product offerings to meet these specific consumer needs. This alignment of regulatory support and consumer demand further enhances Canada's contribution to the regional market, presenting significant opportunities for growth in the plaque modification and removal devices market.

Asia Pacific Market Analysis:

Asia Pacific emerged as the fastest-growing region in the plaque modification and removal devices market, registering a robust CAGR of 9.5%. This growth is primarily driven by the rising prevalence of heart disease, which has spurred demand for advanced medical devices aimed at effectively managing and preventing cardiovascular conditions. The region's healthcare systems are increasingly prioritizing innovative solutions, reflecting a shift in consumer preferences towards more effective and less invasive treatment options. Recent reports from the World Health Organization highlight that heart disease remains a leading cause of mortality in Asia Pacific, prompting governments and healthcare providers to invest in advanced medical technologies. As a result, the market is witnessing a surge in product development, particularly in minimally invasive devices, aligning with the region's sustainability priorities and technological advancements. This dynamic environment positions Asia Pacific as a significant hub for opportunities in the plaque modification and removal devices market, driven by a combination of demographic trends and increasing health awareness among consumers.

Japan plays a pivotal role in the plaque modification and removal devices market, characterized by its advanced healthcare infrastructure and a growing elderly population. The rising heart disease prevalence has led to heightened consumer demand for innovative medical solutions, with a notable shift towards digital health technologies and personalized medicine. According to the Ministry of Health, Labour and Welfare of Japan, cardiovascular diseases account for a substantial portion of healthcare expenditures, prompting a focus on preventive care and early intervention strategies. This has encouraged local manufacturers to enhance their product offerings, integrating advanced technologies such as AI and telemedicine into their devices. As a result, Japan is not only enhancing patient outcomes but also setting a benchmark for quality and innovation in the region, reinforcing Asia Pacific's leadership in the plaque modification and removal devices market.

China is also a key player in the plaque modification and removal devices market, driven by rapid urbanization and an increasing burden of heart disease. The country's healthcare reforms have led to significant investments in medical technology, fostering an environment conducive to innovation and market growth. The National Health Commission of China has reported a surge in cardiovascular disease cases, which has catalyzed the adoption of advanced medical devices among both healthcare providers and patients. This trend is further supported by the growing middle class, which is increasingly willing to invest in health and wellness, leading to a shift in purchasing behavior towards premium medical products. Furthermore, the integration of digital health solutions in China is transforming patient engagement and treatment adherence, creating a more robust market for plaque modification and removal devices. The unique dynamics in China position it as a vital contributor to the overall growth in the Asia Pacific region, enhancing the opportunities within the plaque modification and removal devices market.

Europe Market Trends:

The Europe region holds a commanding share of the plaque modification and removal devices market, driven by an aging population and increasing prevalence of dental diseases. This market's significance is underscored by the region's robust healthcare infrastructure, which promotes advanced treatment options and fosters innovation in medical technologies. Factors such as rising consumer awareness regarding oral health, alongside a strong regulatory framework that emphasizes safety and efficacy, contribute to a favorable environment for market expansion. For instance, the European Commission's initiatives to enhance healthcare access and quality have spurred investments in dental technologies, thereby propelling growth in this sector. Looking ahead, the region presents substantial opportunities for stakeholders, particularly as digital transformation and sustainability priorities reshape the landscape of healthcare delivery.

Germany plays a pivotal role in the Europe plaque modification and removal devices market, characterized by its strong emphasis on technological advancements and high consumer spending in healthcare. The country’s commitment to innovation is reflected in the growing adoption of minimally invasive procedures, which align with patient preferences for efficient and effective treatment options. Notably, the German Dental Association has reported a significant increase in the use of advanced plaque removal technologies, indicating a shift towards more sophisticated dental care solutions. This trend is complemented by the competitive landscape, where local companies are investing in research and development to enhance product offerings. As such, Germany's proactive approach to healthcare innovation positions it as a key driver of regional market opportunities.

France, similarly, maintains a notable presence in the plaque modification and removal devices market, bolstered by a strong regulatory framework that prioritizes patient safety and quality of care. The French government's initiatives to promote preventive healthcare have led to increased consumer engagement in oral health, driving demand for advanced dental technologies. For instance, recent collaborations between French dental associations and technology firms aim to improve access to state-of-the-art plaque removal devices, reflecting a cultural shift towards proactive health management. The competitive landscape in France is marked by a blend of established players and emerging startups, fostering a dynamic environment for innovation. This strategic positioning reinforces France's role in enhancing the overall growth trajectory of the European market, creating synergies that benefit the entire region.

Regional Market Attractiveness & Strategic Fit Matrix
Parameter	North America	Asia Pacific	Europe	Latin America	MEA
Innovation Hub	Advanced	Developing	Advanced	Developing	Nascent
Cost-Sensitive Region	Low	Medium	Low	High	High
Regulatory Environment	Restrictive	Neutral	Restrictive	Neutral	Neutral
Demand Drivers	Strong	Moderate	Strong	Moderate	Weak
Development Stage	Developed	Developing	Developed	Developing	Emerging
Adoption Rate	High	Medium	High	Medium	Low
New Entrants / Startups	Dense	Moderate	Dense	Sparse	Sparse
Macro Indicators	Strong	Stable	Stable	Stable	Weak

Segmentation Analysis

 

Analysis by Application

The plaque modification and removal devices market for coronary artery disease is expected to dominate the segment with a commanding 58.8% share in 2025. This leadership is primarily driven by the high disease prevalence, which continues to escalate due to lifestyle factors and an aging population. The increasing incidence of coronary artery disease has led to heightened demand for effective treatment options, prompting hospitals and healthcare providers to prioritize innovative solutions. Notably, the World Health Organization has reported a significant rise in cardiovascular diseases globally, reinforcing the urgency for advanced medical devices. This segment presents strategic advantages for both established firms and emerging players, enabling them to capitalize on the growing patient base and the need for improved healthcare outcomes. With ongoing advancements in technology and treatment methodologies, the coronary artery disease segment is poised to remain a critical focus in the near to medium term.

Analysis by End Use

The plaque modification and removal devices market in hospitals captured over 68.6% share in 2025, reflecting its pivotal role in the healthcare ecosystem. This dominance is attributed to the advanced surgical facilities that hospitals provide, which are essential for performing complex procedures safely and effectively. As patient expectations evolve towards higher standards of care, hospitals are increasingly investing in state-of-the-art equipment and training to enhance surgical outcomes. The American Hospital Association highlights that hospitals are at the forefront of adopting new technologies to improve patient care, further solidifying their position in this market. This segment creates significant opportunities for both established and emerging players, as hospitals seek partnerships to integrate cutting-edge devices into their surgical suites. Given the ongoing emphasis on improving healthcare delivery and patient safety, the hospital segment is expected to maintain its relevance in the near future.

Analysis by Product

The plaque modification and removal devices market for atherectomy devices represented more than 41.2% of the product segment in 2025, underscoring its critical role in effective plaque removal. This segment's leadership is largely driven by the proven efficacy of atherectomy devices in treating obstructive arterial disease, which is increasingly recognized by healthcare professionals. The American College of Cardiology has endorsed atherectomy as a vital component of comprehensive treatment strategies, contributing to its growing adoption. As healthcare providers prioritize minimally invasive procedures, atherectomy devices align well with patient preferences for quicker recovery times and reduced complications. This segment not only offers established firms a chance to enhance their product portfolios but also allows new entrants to innovate and address unmet clinical needs. With the continuous evolution of medical technology and increasing focus on patient-centric care, the atherectomy devices segment is expected to sustain its importance in the upcoming years.

Report Segmentation
Segment	Sub-Segment
Product	Atherectomy Devices, Thrombectomy Devices, Chronic Total Occlusion Devices, Embolic Protection Devices
Application	Coronary Artery Disease, Peripheral Artery Disease
End Use	Hospitals, Ambulatory Surgical Centers, Others

Competitive Landscape

Key players in the plaque modification and removal devices market include Medtronic, Boston Scientific, Abbott, Philips, Cardiovascular Systems, Terumo, B. Braun, Biotronik, Cordis, and Asahi Intecc. These companies are recognized for their innovative approaches and significant contributions to advancing plaque modification technologies. Medtronic and Boston Scientific, for instance, have established a strong foothold through their extensive product portfolios and commitment to research and development, enabling them to offer cutting-edge solutions. Meanwhile, Abbott and Philips leverage their global reach and diverse capabilities to address various market needs, enhancing their influence within the sector. The presence of established firms like Cardiovascular Systems and Terumo further emphasizes the competitive nature of this market, where innovation and quality are paramount for success.

The competitive landscape in the plaque modification and removal devices market is characterized by dynamic initiatives that shape the strategic positioning of key players. Collaborations among industry leaders, along with significant investments in technology and research, have fostered an environment conducive to innovation. For example, companies are increasingly focusing on developing next-generation devices that integrate advanced technologies, thereby enhancing procedural efficacy and patient outcomes. This emphasis on innovation is complemented by strategic alliances that enable firms to expand their market presence and enhance their product offerings. The ongoing efforts in mergers and acquisitions also reflect a trend toward consolidating expertise and resources, further intensifying competition and driving advancements in the field.

Strategic / Actionable Recommendations for Regional Players

In North America, exploring partnerships with healthcare providers and technology firms could enhance product development and market reach. Engaging in collaborative research initiatives may facilitate the introduction of innovative solutions tailored to meet the specific needs of the local healthcare landscape.

For players in the Asia Pacific region, focusing on leveraging emerging technologies, such as digital health solutions and minimally invasive techniques, presents an opportunity to capture a growing segment of the market. Investing in localized marketing strategies that resonate with regional healthcare priorities could further strengthen their competitive edge.

In Europe, targeting high-growth sub-segments, particularly in aging populations where cardiovascular issues are prevalent, may yield significant rewards. Establishing connections with regulatory bodies and engaging in advocacy efforts can also support market penetration and enhance brand positioning in a competitive environment.